Compare CUBI & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CUBI | NEOG |
|---|---|---|
| Founded | 1994 | 1981 |
| Country | United States | United States |
| Employees | 790 | 1456 |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | N/A | 1995 |
| Metric | CUBI | NEOG |
|---|---|---|
| Price | $66.24 | $8.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $86.63 | $10.67 |
| AVG Volume (30 Days) | 357.6K | ★ 2.2M |
| Earning Date | 04-23-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $894,661,000.00 |
| Revenue This Year | $25.24 | N/A |
| Revenue Next Year | $9.30 | $1.67 |
| P/E Ratio | ★ $11.78 | $98.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.75 | $3.87 |
| 52 Week High | $82.56 | $11.43 |
| Indicator | CUBI | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 28.79 |
| Support Level | $64.71 | $4.74 |
| Resistance Level | $68.28 | $10.30 |
| Average True Range (ATR) | 2.37 | 0.47 |
| MACD | 0.00 | -0.23 |
| Stochastic Oscillator | 32.53 | 4.66 |
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.